About: Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China
Creator	Wang, Xi Deng, Xiaoxian Jin, Bowen Qiu, Qiu Yan, Menghuan Zhang, Gangcheng Zheng, Xuan Zhou, Hongmei
Source	Medline; PMC
abstract	Pulmonary hypertension is a chronic disease developing progressively with high mortality. Pulmonary hypertension patients need persistent medical care; however, limited reports focused on them when there was an outbreak of coronavirus disease 2019 in China. This national survey was aimed to evaluate the overall condition of pulmonary hypertension patients during this period. A questionnaire regarding the living condition of pulmonary hypertension patients during coronavirus disease 2019 was designed by pulmonary hypertension diagnostic experts in Wuhan Asia Heart Hospital. Pulmonary hypertension patients and their family members were invited to participate in this survey online. One-hundred twenty pulmonary hypertension patients and 23 family members participated in the survey; 64.8% (n = 87) participants came from Hubei, and others were from 15 other provinces; 98.6% (n = 141) participants were in home quarantine; 65.8% (n = 79) were pulmonary arterial hypertension associated with congenital heart disease; and 76.7% (n = 92) patients proclaimed their heart function was well maintained at class I or II. One (0.8%) patient was confirmed severe acute respiratory syndrome coronavirus 2 infection. Two (1.7%) patients were hospitalized due to heart function worsening. Nearly 70% (n = 100) participants implied shortage in medications during coronavirus disease 2019 outbreak. A total of 24.2% (n = 29) patients indicated that medications were discontinued due to the insufficient supply. Most of the participants stayed optimistic on either coronavirus disease 2019 outbreak or their pulmonary hypertension disease, and 61.7% (n = 74) patients would go to the hospital for follow-up immediately after outbreak. These preliminary data show pulmonary hypertension patients are able to avoid severe disease when they are in home quarantine. Medication supplement is important for pulmonary hypertension patients when their heart function is well maintained. In addition, there might be increasing requirements of medical care for pulmonary hypertension patients after the outbreak.
has issue date	2020-05-18(xsd:dateTime)
bibo:doi	10.1177/2045894020924566
bibo:pmid	32523686
has license	cc-by-nc
sha1sum (hex)	05232635a5cc30ce5fe029c9903db924cdbed52e
schema:url	https://doi.org/10.1177/2045894020924566
resource representing a document's title	Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China
has PubMed Central identifier	PMC7235682
has PubMed identifier	32523686
schema:publication	Pulm Circ
resource representing a document's body	covid:05232635a5cc30ce5fe029c9903db924cdbed52e#body_text
is schema:about of	named entity 'Pulmonary hypertension' named entity 'participants' named entity 'outbreak' named entity 'Two' named entity 'addition' named entity 'disease' named entity 'mortality' named entity 'pulmonary hypertension' named entity 'Pulmonary hypertension' named entity 'pulmonary hypertension' named entity 'This' named entity 'developing' named entity 'coronavirus disease 2019' named entity 'evaluate' named entity 'outbreak' named entity 'outbreak' named entity 'implied' named entity 'pulmonary arterial hypertension' named entity 'care' named entity 'patients' named entity 'Hubei' named entity 'Nearly' named entity 'period' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'pulmonary hypertension' named entity 'coronavirus disease 2019' named entity 'quarantine' named entity 'hypertension' named entity 'Hubei' named entity 'pulmonary hypertension' named entity 'pulmonary hypertension' named entity 'heart function' named entity 'national survey' named entity 'fever' named entity 'infectious disease' named entity 'COVID-19 outbreak' named entity 'Treprostinil' named entity 'COVID-19' named entity 'COVID-19 outbreak' named entity 'Wuhan' named entity 'heart failure' named entity 'etiology' named entity 'medical care' named entity 'Macitentan' named entity 'NYHA' named entity 'China' named entity 'mmHg' named entity 'anxiety' named entity 'Macitentan' named entity 'anxiety' named entity 'Ethics' named entity 'COVID' named entity 'cough' named entity 'mental condition' named entity 'infection' named entity 'mmHg' named entity 'COVID' named entity 'medical care' named entity 'etiologies' named entity 'COVID-19 outbreak' named entity 'Bosentan' named entity 'China' named entity 'Student's t-test' named entity 'Wuhan' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'COVID-19 outbreak' named entity 'COVID' named entity 'COVID' named entity 'interquartile range' named entity 'COVID' named entity 'Combination therapy' named entity 'pulmonary hypertension' named entity 'Congenital Heart Disease'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software